Objectives:

At the end of this session, participants will be able to

• Outline glaucoma issues in the management of corneal transplants

• Outline the latest evidence in keratoconus management.

• Define the signs and symptoms of Limbal Stem Cell Deficiency

• Describe the treatment modalities currently in use to treat Limbal Stem Cell Deficiency

• Identify visual outcomes used in CNS inflammatory disorders

• Describe the benefits and risk of micropulse transscleral cyclophotocoagulation for adult and pediatric glaucoma